| 抗血管内皮生长因子(VEGF)治疗与视网膜下纤维化研究进展 |
| |
| 引用本文： | 吕亚男,宫媛媛.抗血管内皮生长因子(VEGF)治疗与视网膜下纤维化研究进展[J].眼科新进展,2017(6):583-586. |
| |
| 作者姓名： | 吕亚男 宫媛媛 |
| |
| 作者单位： | 上海交通大学附属第一人民医院眼科,上海市,200080 |
| |
| 基金项目： | 国家自然科学基金项目(81300774)，上海市自然科学基金项目(编号:12ZR1424500)上海市眼底病重点实验室开放课题基金项目(07Z22911)，National Natural Science Foundation of China(81300774)，Natural Science Foundation of Shanghai(12ZR1424500)，Open Fund Project in Ocular Founds Disease Key Laboratory of Shanghai(07Z22911) |
| |
| 摘 要： | 视网膜下纤维化是导致年龄相关性黄斑病变视力丧失的原因之一,抗血管内皮生长因子治疗是目前对于湿性年龄相关性黄斑变性标准治疗方案.本文主要探讨视网膜纤维化的影响因素,抗血管内皮生长因子治疗与视网膜纤维化的关系以及抗视网膜下纤维化的研究进展.
|
| 关 键 词： | 视网膜下纤维化 年龄相关性黄斑变性 抗血管内皮生长因子 |
Anti-VEGF therapy and subretinal fibrosis |
| |
| LV Ya-Nan,GONG Yuan-Yuan.Anti-VEGF therapy and subretinal fibrosis[J].Recent Advances in Ophthalmology,2017(6):583-586. |
| |
| Authors: | LV Ya-Nan GONG Yuan-Yuan |
| |
| Abstract: | Subretinal fibrosis contributes to the loss of vision associated with agerelated macular degeneration.Anti-vascular endothelial growth factor therapy is the current standard treatment for exudative age-related macular degeneration.In this review,many risk factors of subretinal fibrosis are discussed,the relationship between anti-vascular endothelial growth factor therapy and subretinal fibrosis,some potential novel therapeutic methods to suppresses subretinal fibrosis are also revealed. |
| |
| Keywords: | subretinal fibrosis age-related macular degeneration anti-vascular endothelial growth factor |
| 本文献已被 万方数据 等数据库收录！ |
